Publicación:
High Seroprevalence of Antibodies against Arboviruses among Pregnant Women in Rural Caribbean Colombia in the Context of the Zika Virus Epidemic

Vista sencilla de ítem
dc.contributor.authorMarbán Castro, Elena
dc.contributor.authorArrieta Bernate, Germán Javier
dc.contributor.authorMartínez, Miguel J.
dc.contributor.authorGonzález, Raquel
dc.contributor.authorBardají, Azucena
dc.contributor.authorMenéndez, Clara
dc.contributor.authorMattar Velilla, Ameth Salim
dc.contributor.corporatenameCorporación Universitaria del caribe - CECAR
dc.contributor.researchgroupSalud Pública y Auditoría en Salud
dc.date.accessioned2025-09-02T20:07:38Z
dc.date.issued2020
dc.description.abstractMosquito-borne viruses such as dengue (DENV), chikungunya (CHIKV), and Zika (ZIKV) have spread in recent decades. We aimed to assess seroprevalence of arboviral infections in pregnant women living in Cereté, Caribbean Colombia. In 2016 a cross-sectional facility-based sero-survey study was performed among pregnant women (N = 90). Most of them (66%) reported at least one symptom or sign compatible with arboviral infection over the previous 15 days. All screened women had a positive IgG for DENV, 89% for ZIKV, and 82% for CHIKV. One woman tested positive for ZIKV IgM. This study shows the high exposure among pregnant women to arboviruses in endemic areas, shown by the high seroprevalence of past arboviral infections. Given the evidence on the potential risks of these arboviral infections on pregnancy and infant outcomes, these results highlight the need for continuous epidemiological surveillance of arboviral diseases, particularly among those most of risk of their harmful consequences.
dc.description.researchareaAuditoría en Salud
dc.description.researchareaSalud Pública
dc.format.extent8 páginas
dc.format.extent8 páginas
dc.format.mimetypeapplication/pdf
dc.identifier.eissn2073-4468
dc.identifier.urihttps://repositorio.cecar.edu.co/handle/cecar/10839
dc.language.isoeng
dc.publisher.placeColombia
dc.relation.citationendpage8
dc.relation.citationstartpage1
dc.relation.citationvolumeVolumen 9
dc.relation.ispartofjournalAntibodies
dc.relation.referencesGould, E.; Pettersson, J.; Higgs, S.; Charrel, R.; de Lamballerie, X. Emerging arboviruses: Why today? One Health 2017, 4, 1–13. [CrossRef] [PubMed]
dc.relation.referencesCharlier, C.; Beaudoin, M.-C.; Couderc, T.; Lortholary, O.; Lecuit, M. Arboviruses and pregnancy: Maternal, fetal, and neonatal effects. Lancet. Child. Adolesc. Health 2017, 1, 134–146. [CrossRef]
dc.relation.referencesBasurko, C.; Everhard, S.; Matheus, S.; Restrepo, M.; Hildéral, H.; Lambert, V.; Boukhari, R.; Duvernois, J.-P.; Favre, A.; Valmy, L.; et al. A prospective matched study on symptomatic dengue in pregnancy. PLoS ONE 2018, 13, e0202005. [CrossRef] [PubMed]
dc.relation.referencesLiu, L.E.; Dehning, M.; Phipps, A.; Swienton, R.E.; Harris, C.A.; Klein, K.R. Clinical Update on Dengue, Chikungunya, and Zika: What We Know at the Time of Article Submission. Disaster Med. Public Health Prep. 2017, 11, 290–299. [CrossRef] [PubMed]
dc.relation.referencesAlbuquerque, M.D.F.P.M.D.; Souza, W.V.D.; Araújo, T.V.B.; Braga, M.C.; Miranda Filho, D.D.B.; Ximenes, R.A.D.A.; Filho, D.A.D.M.; Brito, C.A.A.D.; Valongueiro, S.; Melo, A.P.L.D.; et al. The microcephaly epidemic and Zika virus: Building knowledge in epidemiology. Cad. Saude Publica 2018, 34, e00069018. [CrossRef]
dc.relation.referencesFranca, G.V.A.; Schuler-Faccini, L.; Oliveira, W.K.; Henriques, C.M.P.; Carmo, E.H.; Pedi, V.D.; Nunes, M.L.; Castro, M.C.; Serruya, S.; Silveira, M.F.; et al. Congenital Zika virus syndrome in Brazil: A case series of the first 1501 livebirths with complete investigation. Lancet 2016, 388, 891–897. [CrossRef]
dc.relation.referencesvan der Eijk, A.A.; van Genderen, P.J.; Verdijk, R.M.; Reusken, C.B.; Mögling, R.; van Kampen, J.J.A.; Widagdo, W.; Aron, G.I.; GeurtsvanKessel, C.H.; Pas, S.D.; et al. Miscarriage Associated with Zika Virus Infection. N. Engl. J. Med. 2016, 375, 1002–1004. [CrossRef]
dc.relation.referencesHonein, M.A.; Dawson, A.L.; Petersen, E.E.; Jones, A.M.; Lee, E.H.; Yazdy, M.M.; Ahmad, N.; Macdonald, J.; Evert, N.; Bingham, A.; et al. Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy. JAMA 2017, 317, 59–68. [CrossRef]
dc.relation.referencesEppes, C.; Rac, M.; Dunn, J.; Versalovic, J.; Murray, K.O.; Suter, M.A.; Sanz Cortes, M.; Espinoza, J.; Seferovic, M.D.; Lee, W.; et al. Testing for Zika virus infection in pregnancy: Key concepts to deal with an emerging epidemic. Am. J. Obstet. Gynecol. 2017, 216, 209–225. [CrossRef]
dc.relation.referencesMendez, N.; Oviedo-Pastrana, M.; Mattar, S.; Caicedo-Castro, I.; Arrieta, G. Zika virus disease, microcephaly and Guillain-Barre syndrome in Colombia: Epidemiological situation during 21 months of the Zika virus outbreak, 2015–2017. Arch. Public Health 2017, 75, 65. [CrossRef]
dc.relation.referencesMattar, S.; Ojeda, C.; Arboleda, J.; Arrieta, G.; Bosch, I.; Botia, I.; Alvis-Guzman, N.; Perez-Yepes, C.; Gerhke, L.; Montero, G. Case report: Microcephaly associated with Zika virus infection, Colombia. BMC Infect Dis. 2017, 17. [CrossRef] [PubMed]
dc.relation.referencesRodriguez-Morales, A.J.; Cardona-Ospina, J.A.; Ramirez-Jaramillo, V.; Gaviria, J.A.; Gonzalez-Moreno, G.M.; Castrillon-Spitia, J.D.; Lopez-Villegas, A.; Morales-Jimenez, E.; Ramirez-Zapata, V.; Rueda-Merchan, G.E.; et al. Diagnosis and outcomes of pregnant women with Zika virus infection in two municipalities of Risaralda, Colombia: Second report of the ZIKERNCOL study. Travel Med. Infect. Dis. 2018, 25, 20–25. [CrossRef] [PubMed]
dc.relation.referencesBosch, I.; de Puig, H.; Hiley, M.; Carré-Camps, M.; Perdomo-Celis, F.; Narváez, C.F.; Salgado, D.M.; Senthoor, D.; O’Grady, M.; Phillips, M.; et al. Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum. Sci Transl Med. 2017, 9. [CrossRef] [PubMed]
dc.relation.referencesArrieta, G.; Mattar, S.; Villero-Wolf, Y.; Gomezcaceres, L.; Doria, A. Evaluation of serological test of Zika in an endemic area of flavivirus in the Colombian Caribbean. Ann. Clin. Microbiol. Antimicrob. 2019, 18, 29. [CrossRef] [PubMed]
dc.relation.referencesDe Ory, F.; Sánchez-Seco, M.P.; Vázquez, A.; Montero, M.D.; Sulleiro, E.; Martínez, M.J.; Matas, L.; Merino, F.J. Comparative Evaluation of Indirect Immunofluorescence and NS-1-Based ELISA to Determine Zika Virus-Specific IgM. Viruses 2018, 10, 379. [CrossRef] [PubMed]
dc.relation.referencesHuzly, D.; Hanselmann, I.; Schmidt-Chanasit, J.; Panning, M. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Eur. Commun. Dis. Bull. 2016, 21. [CrossRef] [PubMed]
dc.relation.referencesLustig, Y.; Koren, R.; Biber, A.; Zuckerman, N.; Mendelson, E.; Schwartz, E. Screening and exclusion of Zika virus infection in travellers by an NS1-based ELISA and qRT-PCR. Clin. Microbiol. Infect. 2020. [CrossRef] [PubMed]
dc.relation.referencesMatheus, S.; Talla, C.; Labeau, B.; de Laval, F.; Briolant, S.; Berthelot, L.; Vray, M.; Rousset, D. Performance of 2 Commercial Serologic Tests for Diagnosing Zika Virus Infection. Emerg. Infect. Dis. 2019, 25, 1153–1160. [CrossRef]
dc.relation.referencesBlacksell, S.D.; Jarman, R.G.; Gibbons, R.V.; Tanganuchitcharnchai, A.; Mammen, M.P.J.; Nisalak, A.; Kalayanarooj, S.; Bailey, M.S.; Premaratna, R.; de Silva, H.J.; et al. Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection. Clin. Vaccine Immunol. 2012, 19, 804–810. [CrossRef]
dc.relation.referencesLitzba, N.; Schuffenecker, I.; Zeller, H.; Drosten, C.; Emmerich, P.; Charrel, R.; Kreher, P.; Niedrig, M. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J. Virol. Methods 2008, 149, 175–179. [CrossRef]
dc.relation.referencesOviedo-Pastrana, M.; Méndez, N.; Mattar, S.; Arrieta, G.; Gomezcaceres, L. Epidemic outbreak of Chikungunya in two neighboring towns in the Colombian Caribbean: A survival analysis. Arch. Public Health 2017, 75, 1. [CrossRef] [PubMed]
dc.relation.referencesPaniz-Mondolfi, A.E.; Rodriguez-Morales, A.J.; Blohm, G.; Marquez, M.; Villamil-Gomez, W.E. ChikDenMaZika Syndrome: The challenge of diagnosing arboviral infections in the midst of concurrent epidemics. Ann. Clin. Microbiol. Antimicrob. 2016, 15, 42. [CrossRef] [PubMed]
dc.relation.referencesFritzell, C.; Rousset, D.; Adde, A.; Kazanji, M.; Van Kerkhove, M.D.; Flamand, C. Current challenges and implications for dengue, chikungunya and Zika seroprevalence studies worldwide: A scoping review. PLoS Negl. Trop. Dis. 2018, 12, e0006533. [CrossRef]
dc.relation.referencesRocha, L.B.; Alves, R.P.D.S.; Caetano, B.A.; Pereira, L.R.; Mitsunari, T.; Amorim, J.H.; Polatto, J.M.; Botosso, V.F.; Gallina, N.M.F.; Palacios, R.; et al. Epitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal Antibodies. Antibodies 2017, 6, 14. [CrossRef] [PubMed]
dc.relation.referencesJaramillo-Mejía, M.C.; Chernichovsky, D. Early adolescent childbearing in Colombia: Time-trends and consequences. Cad. Saude Publica 2019, 35, e00020918. [CrossRef]
dc.relation.referencesRomero-Acosta, K.; Marbán-Castro, E.; Arroyo, K.; Arrieta, G.; Mattar, S. Perceptions and Emotional State of Mothers of Children with and without Microcephaly after the Zika Virus Epidemic in Rural Caribbean Colombia. Behav. Sci. 2020, 10, 147. [CrossRef]
dc.relation.referencesMarbán-Castro, E.; Villén-Gonzalvo, A.; Enguita-Fernàndez, C.; Marín-Cos, A.; Menéndez, C.; Maixenchs, M.; Bardají, A. Uncertainties, Fear and Stigma: Perceptions of Zika Virus among Pregnant Women in Spain. Int. J. Environ. Res. Public Health 2020, 17, 6643. [CrossRef]
dc.relation.referencesMaslow, J.N. Zika Vaccine Development-Current Progress and Challenges for the Future. Trop. Med. Infect. Dis. 2019, 4, 104. [CrossRef]
dc.relation.referencesGarg, H.; Mehmetoglu-Gurbuz, T.; Joshi, A. Recent Advances in Zika Virus Vaccines. Viruses 2018, 10, 631. [CrossRef]
dc.relation.referencesLaris-González, A.; Bernal-Serrano, D.; Jarde, A.; Kampmann, B. Safety of Administering Live Vaccines During Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes. Vaccines 2020, 8, 134. [CrossRef]
dc.relation.referencesSchwartz, D.A. Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation. Vaccines 2018, 6, 81. [CrossRef] [PubMed]
dc.rightsDerechos reservados - Corporación Universitaria de Caribe - CECAR
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2
dc.rights.licenseAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourcedoi:10.3390/antib9040056
dc.subject.proposalzika
dc.subject.proposalDengue
dc.subject.proposalChikungunya
dc.subject.proposalSeroprevalence
dc.subject.proposalColombia
dc.titleHigh Seroprevalence of Antibodies against Arboviruses among Pregnant Women in Rural Caribbean Colombia in the Context of the Zika Virus Epidemiceng
dc.typeArtículo de revista
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.contentText
dc.type.driverinfo:eu-repo/semantics/article
dc.type.redcolhttp://purl.org/redcol/resource_type/ART
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
High Seroprevalence of Antibodies against Arboviruses among Pregnant Women in Rural Caribbean Colombia in the Context of the Zika Virus Epidemic.pdf
Tamaño:
252.08 KB
Formato:
Adobe Portable Document Format
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
14.49 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

BAF. Salud Pública y Auditoria en Salud (SPAS)